-
Product Insights
GLP Japan – GLP Hayashima III – Okayama
The GLP Japan – GLP Hayashima III – Okayama project involves the construction of an 18,000m2, three-story logistic facility on 1.1ha of land in Hayashima, Okayama, Japan. Equip yourself with the essential tools needed to make informed and profitable decisions with our GLP Japan – GLP Hayashima III – Okayama report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Insulin Icodec + Semaglutide) in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Insulin Icodec + Semaglutide) in Type 2 Diabetes report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Insulin Icodec + Semaglutide) in Type 2 Diabetes...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – GMA-102 in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GMA-102 in Type 2 Diabetes report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GMA-102 in Type 2 Diabetes Drug Details: GMA-102 is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Liraglutide in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Liraglutide in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Liraglutide in Parkinson's Disease Drug Details: Liraglutide (Victoza) is a potent anti-diabetic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Liraglutide in Pouchitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Liraglutide in Pouchitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Liraglutide in Pouchitis Drug Details: Liraglutide (Victoza) is a potent anti-diabetic agent. It...
-
Product Insights
GLP Pte – Tokyo West 1 Hyperscale Data Center – Tokyo
Equip yourself with the essential tools needed to make informed and profitable decisions with our GLP Pte – Tokyo West 1 Hyperscale Data Center – Tokyo report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Acquire a thorough understanding...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NN-9847 in Obesity
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NN-9847 in Obesity report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NN-9847 in Obesity Drug Details: NN-9847 is under development for the treatment of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Maridebart Cafraglutide in Obesity
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Maridebart Cafraglutide in Obesity report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Maridebart Cafraglutide in Obesity Drug Details: Maridebart cafraglutide (AMG-133) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NA-931 in Obesity
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NA-931 in Obesity report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NA-931 in Obesity Drug Details: NA-931 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NN-9931 in Liver Cirrhosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NN-9931 in Liver Cirrhosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NN-9931 in Liver Cirrhosis Drug Details: Semaglutide (NN-9931) is under development...